Effectiveness of Tropisetron Plus Risperidone for Improving Cognitive and Perceptual Disturbances in Schizophrenia

Completed · Phase 3 · Has a placebo group

Conditions studied: Smoking Cessation, Schizophrenia

In brief

This study will determine the effectiveness of tropisetron plus risperidone in improving cognitive symptoms in Chinese people with schizophrenia.

Key facts

Study ID
NCT00435370
Run by
Baylor College of Medicine
People needed
179
Starts
2006-11-01
Expected to finish
2011-08-01
Last updated by the study team
2017-03-15

Who can join

Age: 18 and older, up to 64. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.